Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|15|2586-2593

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.15, 2015-08, pp. : 2586-2593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

Gemcitabine plus Cisplatin in Adjuvant Regimen for Bladder Cancer

By  

Urologia Internationalis, Vol. 71, Iss. 1, 2003-07 ,pp. : 37-40

Karger

Access to resources Recommend Favorite

Remarkable Response to Neoadjuvant Therapy with Methotrexate, Vinblastine, Adriamycin, and Cisplatin for Undifferentiated Bladder Carcinoma: A Case Report and Literature Review

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-11 ,pp. : 746-750

Karger

Access to resources Recommend Favorite

Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 11, 2015-11 ,pp. : 789-794

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weekly Cetuximab and Gemcitabine plus Cisplatin as Salvage Therapy for Unresectable Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 685-686

Karger

Access to resources Recommend Favorite